TAT Technologies (NASDAQ:TATT – Get Free Report) was upgraded by research analysts at Wall Street Zen from a “hold” rating to a “buy” rating in a report released on Friday. Several other research analysts also recently weighed in on the stock. Benchmark began coverage on shares of TAT Technologies in a report on Monday, November […]

Owlet (NYSE:OWLT – Get Free Report) was downgraded by analysts at Wall Street Zen from a “buy” rating to a “hold” rating in a research report issued to clients and investors on Friday. Several other analysts have also issued reports on the company. William Blair started coverage on Owlet in a report on Tuesday, December […]

LifeStance Health Group (NASDAQ:LFST – Get Free Report) was upgraded by research analysts at Wall Street Zen from a “hold” rating to a “buy” rating in a report released on Friday. LFST has been the topic of several other research reports. BMO Capital Markets initiated coverage on shares of LifeStance Health Group in a research […]

Perfect (NYSE:PERF – Get Free Report) was downgraded by Wall Street Zen from a “buy” rating to a “hold” rating in a research note issued to investors on Friday. Separately, Weiss Ratings restated a “sell (d)” rating on shares of Perfect in a research note on Wednesday, October 8th. One investment analyst has rated the […]

Royal Bank Of Canada upgraded shares of Vertex Pharmaceuticals (NASDAQ:VRTX – Free Report) from a sector perform rating to an outperform rating in a research note issued to investors on Thursday, MarketBeat reports. Royal Bank Of Canada currently has $546.00 price objective on the pharmaceutical company’s stock, up from their previous price objective of $455.00. […]

Cognizant Technology Solutions (NASDAQ:CTSH – Get Free Report) was upgraded by research analysts at Berenberg Bank to a “strong-buy” rating in a research note issued to investors on Thursday,Zacks.com reports. A number of other equities analysts have also commented on the stock. Citigroup reiterated a “neutral” rating and issued a $86.00 price objective (up previously […]

Red Violet (NASDAQ:RDVT – Get Free Report) was downgraded by equities research analysts at Wall Street Zen from a “strong-buy” rating to a “buy” rating in a research note issued on Friday. Several other equities research analysts have also weighed in on RDVT. Lake Street Capital reaffirmed a “buy” rating and issued a $62.00 target […]